https://www.moneycontrol.com/news/business/markets/glenmark-launches-biosimilar-of-anti-diabetic-drug-vows-to-cut-down-therapy-cost-by-70-11991461.html
0
0
1/3/24 at 4:50am
Organization
Moneycontrol
Author
Neethi Rojan
42 words
0
Comments
Priced at around Rs 100 for a standard dose of 1.2 mg (per day), this will lower the cost of therapy by approximately 70 percent
You are the first to view
Create an account
or login to join the discussion